SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-181574
Filing Date
2010-08-06
Accepted
2010-08-06 17:09:35
Documents
7
Period of Report
2010-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19850
2 OPINION OF AKERMAN SENTERFITT dex51.htm EX-5.1 10155
3 SECURITIES PURCHASE AGREEMENT, DATED AS OF AUGUST 5, 2010, BETWEEN THE COMPANY dex101.htm EX-10.1 124280
4 SECURITIES PURCHASE AGREEMENT, DATED AS OF AUGUST 5, 2010, BETWEEN THE COMPANY dex102.htm EX-10.2 124349
5 PRESS RELEASE dex991.htm EX-99.1 7632
6 GRAPHIC g65057ex5_1pg001.jpg GRAPHIC 5547
7 GRAPHIC g65057ex99_1pg01.jpg GRAPHIC 10940
  Complete submission text file 0001193125-10-181574.txt   310854
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 10999159
SIC: 2834 Pharmaceutical Preparations